Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 21, 2018 ) GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in 2017. The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.
The pharmaceutical and healthcare industry recorded a marginal increase in the number of number deals and a decrease in deal values in 2017 with 4,840 deals worth USD362 billion, as compared to 4,838 deals worth USD404.9 billion in 2016. The oncology market recoded 1,654 deals in 2017, as compared to 1,596 deals in 2016. North America recorded a decrease in the number of deals and deal values with 3,040 deals worth USD225.8 billion in 2017, as compared to 3,148 deals worth USD271.6 billion in 2016. Licensing agreements recorded a marginal increase in the receipt of upfront payments with USD4.4 billion in 2017, as compared to USD4.3 billion in 2016.
Request a Sample PDF of Pharmaceuticals Report@ http://orbisresearch.com/contacts/request-sample/2129284
Scope:
- Analysis of the market trends for the pharmaceutical industry in the global arena. - Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments. - Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry. - Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As. - Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry. - Analysis of partnership and licensing deals based on clinical stage of development of products. - Summary of the pharmaceutical deals globally in the five years. - Information on the top deals happened in the pharmaceutical industry. - Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. - League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Have any query? Feel free to ask us@ http://orbisresearch.com/contacts/enquiry-before-buying/2129284 Reasons to buy:
- Enhance your decision making capability in a more rapid and time sensitive manner. - Find out the major deal performing segments for investments in your industry. - Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets. - Identify companies that are aggressively looking to raise capital in the market - Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry. - Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies. - Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening. - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry. - Identify growth segments and opportunities in each region within the industry. - Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
Some Points from TOC:
1 Table of Contents 2 2 Pharmaceutical & Healthcare, Global, Deals Summary 13 3 Pharmaceuticals & Healthcare, Global, Deal Summary, by Type 25 4 Pharmaceuticals & Healthcare, Global, Deal Summary, By Market 77 5 Pharmaceuticals & Healthcare, Deal Summary, By Geography 113 6 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 133 7 Further Information 136
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Browse full report with TOC@ http://orbisresearch.com/reports/index/partnerships-licensing-investments-and-m-and-a-deals-and-trends-for-2017-in-pharmaceuticals
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Orbis Research
Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|